Absence of BRINP1 in mice causes increase of hippocampal neurogenesis and behavioral alterations relevant to human psychiatric disorders by Miwako Kobayashi et al.
Kobayashi et al. Molecular Brain 2014, 7:12
http://www.molecularbrain.com/content/7/1/12RESEARCH Open AccessAbsence of BRINP1 in mice causes increase of
hippocampal neurogenesis and behavioral
alterations relevant to human psychiatric
disorders
Miwako Kobayashi1, Toshiyuki Nakatani2, Toshiaki Koda3, Ken-ichi Matsumoto4, Ryosuke Ozaki1, Natsuki Mochida1,
Keizo Takao5,6, Tsuyoshi Miyakawa5,6,7 and Ichiro Matsuoka1*Abstract
Background: We have previously identified BRINP (BMP/RA-inducible neural-specific protein-1, 2, 3) family genes
that possess the ability to suppress cell cycle progression in neural stem cells. Of the three family members, BRINP1
is the most highly expressed in various brain regions, including the hippocampus, in adult mice and its expression
in dentate gyrus (DG) is markedly induced by neural activity. In the present study, we generated BRINP1-deficient
(KO) mice to clarify the physiological functions of BRINP1 in the nervous system.
Results: Neurogenesis in the subgranular zone of dentate gyrus was increased in BRINP1-KO mice creating a more
immature neuronal population in granule cell layer. The number of parvalbumin expressing interneuron in hippocampal
CA1 subregion was also increased in BRINP1-KO mice. Furthermore, BRINP1-KO mice showed abnormal behaviors with
increase in locomotor activity, reduced anxiety-like behavior, poor social interaction, and slight impairment of working
memory, all of which resemble symptoms of human psychiatric disorders such as schizophrenia and attention–deficit/
hyperactivity disorder (ADHD).
Conclusions: Absence of BRINP1 causes deregulation of neurogenesis and impairments of neuronal differentiation in
adult hippocampal circuitry. Abnormal behaviors comparable to those of human psychiatric disorders such as
hyperactivity and poor social behavior were observed in BRINP1-KO mice. These abnormal behaviors could be caused by
alteration of hippocampal circuitry as a consequence of the lack of BRINP1.
Keywords: Hippocampal neurogenesis, Interneuron, Behavior, Psychiatric disorderBackground
Elucidation of the molecular and pathological mecha-
nisms in the onset of human psychiatric disorders such
as schizophrenia remains a great challenge in molecular
neuroscience, partly because of the complexity of the dis-
eases with both numerous genetic risk factors and various
environmental factors. The lack of quantifiable biological
indicators has also hindered objective analyses in human
subjects. Therefore, the development of animal models
with homogeneous backgrounds should help in clarifying* Correspondence: imatsuok@cc.matsuyama-u.ac.jp
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psychiatric disorders.
Since endophenotype is a concept that lies between gen-
etics and disease, identification and analysis of the endo-
phenotype should contribute towards an understanding of
the complicated mechanisms of the development of psy-
chiatric disorders and so to finding a good predictor of the
onset of the diseases. Therefore, searches for common
phenotypes including structural and behavioral alterations
within a group of mutant mice can help us establish the
endophenotypes related to particular human psychiatric
disorders [1,2]. In this regard, recent studies using a com-
prehensive behavioral test battery revealed that mutant
mice of both susceptible and non-susceptible genes ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mal behaviors relevant to the symptoms of psychiatric
disorders [3].
BRINP1 (BMP/RA-induced neural specific protein-1) was
identified as a gene which is induced during differentiation
of peripheral neurons [4]. With subsequently identified
members, BRINP2 and BRINP3, BRINP1 forms a novel
protein family (BRINP family). Although the primary struc-
tures of these three BRINPs show almost no similarity to
any known proteins, they are evolutionally conserved at ex-
tremely high levels in vertebrates from fish to mammals
[4]. In the mouse nervous system, mRNA of the three
BRINPs become detectable from E9.5 and continues to ex-
press in adulthood, each with a distinctive pattern. Of these
BRINP family genes, BRINP1 is most highly expressed in
various brain regions, such as hippocampus, cortex, olfac-
tory bulbs, striatum and cerebellum [4]. We have previ-
ously shown that over-expressed BRINPs suppress cell
cycle progression in non-neural cells [4] and neural stem
cells [5]. Moreover, the induction of BRINP1-mRNA in
hippocampus by glutamatergic stimulation suggested that
BRINP1 possesses a plasticity-related physiological func-
tion in the hippocampus [6].
The hippocampus plays key roles in spatial navigation
and memory formation, and its functional impairment
causes various neurological disorders such as Alzheimer’s
disease, epilepsy and schizophrenia. The subgranular zone
(SGZ) of the dentate gyrus (DG) in hippocampus is one of
two restricted regions where neurogenesis regularly occurs
in normal adult mammalian brain [7,8]. It has been shown
that newborn neuronal precursor cells in SGZ differenti-
ate into dentate granule cells, migrate into inner granule
cell layer and are integrated into neuronal circuitry [9,10].
These adult-born granule neurons are thought to play
important roles in memory formation [11] such as me-
diating spatial information processing [12]. Numerous
studies showed that up- or down-regulation of adult neuro-
genesis can affect hippocampus-dependent behaviors [13].
In the present study, to elucidate the physiological func-
tions of BRINP1 in the adult brain we generated BRINP1-
KO mice and analyzed their phenotypes on various aspects
such as neurogenesis, neuronal differentiation and behav-
ioral alterations with specific attention to hippocampal
functions. Consequently, we found that the neurogenesis in
SGZ was significantly increased, creating a more immature
neuronal population in BRINP1-KO mice. The number of
parvalbumin expressing interneurons was also increased in
hippocampal CA1 subregion in BRINP1-KO mice. Further-
more, we found abnormal behaviors of BRINP1-KO mice
which resemble behaviors associated with certain human
psychiatric conditions. From these results, we discuss the
possible molecular functions of BRINP1 to regulate neuro-
genesis, neuronal differentiation and survival in hippocam-
pal circuitry.Results
Generation of BRINP1-KO mice
BRINP1-KO mice were designed to replace Brinp1 exon8
with neomycin resistant gene (Figure 1A). Homologous
recombination of genomic DNA in embryonic stem (ES)
cells and F1 mice was confirmed by Southern blot analysis
that produced 6.9 kb and 9.6 kb BamHI fragments hybrid-
ized with 5’ probe (Figure 1B-C). Northern hybridization
with Brinp1 exon8-cRNA probe showed that BRINP1-
mRNA was absent in the adult brain of BRINP1-KO mice
(Figure 1D). Loss of BRINP1 expression did not alter
mRNA levels of BRINP2 or BRINP3, the other members
of BRINP family genes, suggesting that there is no compen-
sation of mRNA expression among BRINP family genes in
BRINP1-KO mice. BRINP1 homozygous KO mice showed
a normal appearance at birth and had normal skeleton. The
body weight of BRINP1-KO mice (22.38 ± 0.45 g) was
about 85% of wild-type (WT) littermates (26.22 ± 0.38 g) at
adult stage (Figure 2A). However, there were no significant
differences in the weights of either brain or hippocampus
between BRINP1-KO and wild-type mice (i.e. brain weight,
WT; 774.4 ± 71.3 mg (n = 5), BRINP1-KO; 697.4 ± 96.4 mg
(n = 11), hippocampal weight per mouse, WT; 24.6 ±
2.3 mg (n = 10), BRINP1-KO; 25.8 ± 1.8 mg (n = 12)).
Behavioral alterations in BRINP1-KO mice
To examine the effects of disruption of BRINP1 gene on
mouse behavior, we performed a comprehensive behav-
ioral test battery [14] on BRINP1-KO mice. First we ex-
amined general health and conducted neurological tests.
As mentioned above, body weight was substantially re-
duced in BRINP1-KO mice compared to that of wild-type
littermates. The higher locomotor activity of BRINP1-KO
mice in home cage may explain the decrease of body-
weight (see Additional file 1: Figure S1A). Body tempera-
ture (Figure 2B) and sensory abilities of BRINP1-KO mice
appeared to be normal (Figure 2E). BRINP1-KO mice
showed normal levels of neuromuscular strength in grip
strength test (Figure 2C). On the other hand, BRINP1-KO
mice showed a remarkably short latency compared to
wild-type mice in the wire hang test (Figure 2D). BRINP1-
KO mice also showed shorter latency than wild-type
mice in the fall from the rotating drum in Rotarod test
(Figure 2F). Since BRINP1-KO mice improved their per-
formance during the repeating trials of Rotarod test in a
similar manner to wild-type mice, it seems that their
ability to learn motor skills did not decline. These re-
sults suggest that either motor coordination was im-
paired in BRINP1-KO mice or they are mentally less
patient than wild-type mice.
Exploratory activity was assessed with the open field tests.
Throughout the 120 min observation period BRINP1-KO
mice showed more than 1.5 times higher locomotor/ex-
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Figure 1 Targeted disruption of BRINP1 gene in ES cell and mouse. (A) Construct of the targeting vector for homologous recombination to
yield BRINP1-KO mice. The coding region of Brinp1 exon8 (filled box) was disrupted by PGK-neomycin resistance cassette. The probe used for
Southern blot analysis is shown together with predicted sizes of hybridizing fragments. Sites of restriction enzymes: Av, AvrII; B, BamHI; H, HindIII;
Ps, PstI; RV, EcoRV; Xc, XcmI; Xm, XmaI. (B) Southern blot analysis of BamHI-digested genomic DNA extracted from control (TT2) and positive clone
(1–9) of ES cells, and F1 mice produced by crossing chimera mice with C57BL/6J mice. (C) Southern blot analysis of genomic DNA extracted from
wild-type (+/+) and BRINP1-KO (−/−) mice. (D) mRNA expression of BRINP family genes in BRINP1-KO mice. Total RNA extracted from adult brain
of wild-type (+/+), BRINP1 heterozygous (+/−), and BRINP1-KO (−/−) mice were hybridized with each of Brinp1, Brinp2 and Brinp3 antisense
probes. Uniform transfer of RNA was confirmed by methylene blue staining.
Kobayashi et al. Molecular Brain 2014, 7:12 Page 3 of 16
http://www.molecularbrain.com/content/7/1/12spent in the center area of the test apparatus of BRNP1-KO
mice was markedly longer than that of wild-type mice and
the difference was highly significant during the first 60 min
of the test (Figure 3C). This result suggests that BRINP1-
KO mice are less fearful in the open field. Although there
was no significant difference in vertical activity and stereo-
typic behavior between BRINP1-KO mice and wild-type
mice, BRINP1-KO had a tendency to show less vertical ac-
tivity and more stereotypic behavior compared to wild-type
mice. (Figure 3B and 3D). These results from the openfield test indicate that the increased locomotor activity in
BRINP1-KO mice is accompanied by reduced anxiety.
Anxiety-related behavior was also assessed by the light/
dark transition test (Figure 4A-D) and the elevated plus
maze test (Figure 4E-H) [15]. In the former test, BRINP1-
KO mice traveled 1.54- and 1.34-fold longer distances than
wild-type mice in both light (WT; 722 ± 45 cm (n = 11),
BRINP1-KO; 1113 ± 138 cm (n = 9)) and dark boxes (WT;
1647 ± 48 cm (n = 11), BRINP1-KO; 2200 ± 150 cm (n = 9)),






























































































Figure 2 General health and neurological screening of BRINP1-KO mice. (A) Body weight of BRINP1-KO mice was reduced to about 85% of
wild-type mice. (B) Body temperature was measured at rectum. (C) Grip strength of forelimb in Newton. (D) Latency to fall (s) showed in wire
hang test. (E) Hot plate test at 55°C. (F) Rotarod test. (wild-type mice, n = 11; BRINP1-KO mice, n = 9) Error bars indicate SEM.
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sitions between dark and light boxes was 1.62-fold higher
in BRINP1-KO mice than in wild-type mice (WT; 33 ± 1.7
(n = 11), BRINP1-KO; 53 ± 5.5 (n = 9)) (Figure 4C). Add-
itionally, BRINP1-KO mice had the tendency to spend
longer time in the light box than did wild-type mice
(Figure 4B). On the other hand, there was no signifi-
cant difference in latency of the first entry into the light
box from the dark box between each mouse genotype
(Figure 4D). These results from light/dark transition test
also indicate that BRINP1-KO mice are hyperactive. In
the elevated plus maze test, BRINP1-KO mice showed
a 1.43-fold longer travel distance than wild-type mice
(WT; 1926 ± 126 cm (n = 11), BRINP1-KO; 2760 ± 147 cm
(n = 9)) (Figure 4G), a similar extent to the open field test
(Figure 3A) and light/dark transition (Figure 4A). In ac-
cordance with the increased travel distances, BRINP1-KO
mice showed 1.53-fold more frequent entries into the
arms (WT; 40 ± 5 (n = 11), BRINP1-KO; 61 ± 8 (n = 9))
(Figure 4E). It was inferred that BRINP1-KO mice showed
less anxiety from the fact that BRINP1-KO mice had the
tendency to enter 1.82-fold more frequently into the open
arms (WT; 19.6 ± 3.9% (n = 11), BRINP1-KO; 35.6 ± 8.5%(n = 9)) (Figure 4F) and spent 2.21-fold longer time in
the open arms than did wild-type mice (WT; 7.4 ± 2.4%
(n = 11), BRINP1-KO; 16.3 ± 4.5% (n = 9)) (Figure 4H).
These results from elevated plus maze test again indicate
that the increased locomotor activity in BRINP1-KO mice
is accompanied by reduced anxiety.
In the social interaction test in a novel environment,
BRINP1-KO mice traveled 1.42-fold longer distances than
wild-type mice (WT; 3985 ± 282 cm (n = 11), BRINP1-KO;
5641 ± 272 cm (n = 9)) in accordance with other tests men-
tioned above (Figure 5E). However, both the total duration
of contacts (WT; 96 ± 9 s (n = 5); BRINP1-KO; 38 ± 8 s
(n = 4)) and the mean duration per contact (WT; 1.5 ± 0.2
(n = 5); BRINP1-KO; 0.8 ± 0.05 (n = 4)) of BRINP1-KO
mice were 61% and 50% less than those of wild-type mice,
respectively (Figure 5A and 5D). BRINP1-KO mice had
the tendency to show a smaller number of total contacts
and shorter total duration of active contacts than wild
type mice, although differences were not statistically sig-
nificant (Figure 5B-C). On the other hand, BRINP1-KO
mice showed a similar contact pattern in the home cage
to wild type mice (see Additional file 1: Figure S1B).
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BRINP1-/- (n=9) 
Figure 3 Exploratory activity in BRINP1-KO mice in open field test. (A) Total distance traveled. (B) Counts of vertical activity. (C) Time spent
in the center of the compartment. (D) Counts of stereotypic behavior. (wild-type mice, n = 11; BRINP1-KO mice, n = 9) Error bars indicate SEM.
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cial interaction when encountering an unfamiliar mouse.
Working memory of mice was assessed by T-maze alter-
ation test. Percentages of correct responses of BRINP1-KO
mice were considerably lower than that of wild-type mice
at the certain blocks of 3 sessions during repetitive ses-
sions with short delay period (3 s) (Figure 6A). Although
BRINP1-KO mice traveled similar distances compared
to wild-type mice during the T-maze test (Figure 6C),
they performed the test in shorter time than wild-type
mice (Figure 6B). When difficulty of the task was raised
by prolonging the delay period (≥30 s), BRINP1-KO
mice showed lower performances than wild-type mice
(Figure 6D). These results suggest that mild impairment
of working memory of BRINP1-KO mice became appar-
ent when the difficulty level was raised.Histochemical alterations in BRINP1-KO mice
From the comprehensive behavioral test battery it was re-
vealed that BRINP1-KO mice show several abnormal be-
haviors: increased locomotor activity, decreased anxiety-like
behavior, poor social interaction, and mild deficit of work-
ing memory. Since BRINP1-mRNA was highly expressed in
the hippocampus and further up-regulated in the dentate
gyrus in an activity-dependent manner [4,6], we examined
the course of differentiation of dentate granule neurons inBRINP1-KO to elucidate the biological basis of the abnor-
mal behavior.
To assess the level of adult neurogenesis in SGZ, we
examined the number of 5-bromo-2’-deoxyuridine (BrdU)-
positive neurons in SGZ after an intraperitoneal injection
of BrdU as well as the number of Ki-67-positive neurons in
7 to 10-week-old mice. As a result, the immunoreactivities
of both incorporated-BrdU and Ki-67 were noticeably
increased in SGZ of 8-week-old BRINP1-KO mice com-
pared to wild-type mice (Figure 7A-D). At 7 and 8-
weeks, the average number of BrdU-positive cells per
section in BRINP1-KO mice was 1.65- and 1.94-fold greater
than those in wild-type mice, respectively (Figure 7E). The
number of Ki-67-positive cells in SGZ was also increased in
the BRINP1-KO mice in a similar manner to the BrdU-
positive cells. On the other hand, in SGZ of 10-week-old
mice, there were no obvious differences in the numbers of
BrdU- and Ki-67-positive cells between BRINP1-KO mice
and wild-type mice (data not shown). These results suggest
that BRINP1 function in the hippocampus of normal ani-
mals is to suppress neurogenesis in SGZ. Developing den-
tate granule neurons as well as adult born dentate neurons
express several marker proteins depending on their levels
of maturation. In the dentate gyrus of 7-week-old BRINP1-
KO mice, staining of doublecortin (DCX), a marker for
neuroblast and immature neurons [16,17], was stronger














































































































Figure 5 Social interaction of BRINP1-KO mice in novel environment. (A) Total duration of contacts. (B) Total number of contacts. (C) Total
duration of active contacts which either of the mice traveled longer than 5 cm. (D) Mean duration per contacts. (E) Total distance traveled.
(wild-type mice, n = 5; BRINP1-KO mice, n = 4) Error bars indicate SEM.
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p=0.0328 p=0.0843 p=0.0004 p=0.0787
WT (n=11)
BRINP1-/- (n=9)
Figure 4 Anxiety-related behavior of BRINP1-KO mice in light/dark transition and elevated plus maze. (A-D) Light/dark transition,
(E-H) Elevated plus maze test. (A) Total distance traveled in the light and dark boxes. (B) Time the mice stayed in the light box. (C) Number of
transitions between light and dark boxes. (D) Latency time before the first entry into the light box. (E) Number of entries into each open and
closed arm. (F) Percent of entries into the open arms. (G) Total distance traveled. (H) Percent time spent on the open arms. (wild-type mice, n = 11;
BRINP1-KO mice, n = 9) Error bars indicate SEM.
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Figure 6 Working memory of BRINP1-KO mice in T-maze test. (A) Percentage of correct responses in free-choice run. (B) Latency to
complete one session. (C) Distance traveled within one session. (D) Percentage of correct responses when each delay duration was inserted
between forced-choice run and free-choice run. (wild-type mice, n = 11; BRINP1-KO mice, n = 9) Error bars indicate SEM.
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mature neurons and calbindin, a marker of mature neurons
in BRINP1-KO mice were similar to those in wild-type
mice (Figure 8C-F).
We traced the differentiation of the BrdU-incorporated
cells in SGZ with double immunostaining of BrdU and
cell type-specific markers; nestin, GFAP, DCX, calretinin,
and calbindin. BrdU was administered to both wild-type
and BRINP1-KO mice at 11 weeks old and analyzed at dif-
ferent time points from 1 to 5 weeks after BrdU adminis-
tration. At 2 weeks after administration, 3 times more
DCX/BrdU double positive cells were found in BRINP1-
KO mice than in wild-type mice. On the other hand, at 4
or 5 weeks after BrdU administration, the numbers of cal-
bindin/BrdU double positive cells were almost the same in
both genotypes. These results suggest that in BRINP1-KO
mice, the excess newborn neurons in SGZ continue to dif-
ferentiate to some extent (i.e. to DCX-positive immature
neurons) until 2 weeks after their birth, but cannot dif-
ferentiate further or survive thereafter. Representative
images of the DCX/BrdU double positive cells are shown
in Additional file 1: Figure S2.
To assess the development of interneuron and glial
cells in hippocampus of BRINP1-KO mice, we examinedimmunostaining of those markers. There was no differ-
ence in hippocampal expressions of both glial fibrillary
acidic protein (GFAP), a marker for astrocyte, and Iba1,
a marker for microglia between BRINP1-KO and wild-type
mice (see Additional file 1: Figure S3). The expression level
of myelin basic protein (MBP), a marker for oligodendro-
cyte was also similar in both genotypes (see Additional
file 1: Figure S4). The expression level of glutamic acid
decarboxylase 67 (GAD67), a common marker for inhibitory
interneuron, was also similar in both BRINP1-KO and
wild-type mice hippocampus (see Additional file 1: Figure
S5). The numbers of large size intensive parvalbumin-
expressing neurons in CA2/3 subregion and dentate gyrus
are similar in both genotypes, whereas the number of
parvalbumin-expressing neurons in CA1 subregion in
BRINP1-KO mice was 1.65-fold higher than that in wild-
type mice (Figure 9). These results suggest that loss of
BRINP1 did not affect the development of glial lineage but
increased the population of parvalbumin-expressing inter-
neurons in hippocampal CA1 subregion.
Discussion
In the present study, from the phenotypic analysis of




































Figure 7 Adult neurogenesis is increased in BRINP1-KO mice. Representative images of BrdU positive cells (green) (A,B) and Ki-67 positive
cells (red) (C,D) in dentate gyrus of wild-type mice (A,C) and BRINP1-KO mice (B,D) at 8 weeks. DAPI in blue. (E) Representative graph of the
number of BrdU-positive and Ki-67-positive cells in each 7 and 8-week-old mouse dentate gyrus. Data are shown as mean ± SEM. (n = 35 sections
per genotype; **: p < 0.01, ***: p < 0.001 Wilcoxon rank-sum test). Scale bar; 100 μm.
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campal circuitry, such as regulation of neurogenesis and
neuronal differentiation. Increase of neurogenesis in den-
tate SGZ and subsequent increase in the population of im-
mature neurons were found in BRINP1-KO mice. The
number of parvalbumin expressing interneurons was in-
creased in hippocampal CA1 subregion of BRINP1-KO
mice. In addition to these phenotypes, BRINP1-KO mice
showed a set of abnormal behaviors: increase in loco-
motor activity, decreased anxiety-like behavior, poor social
interaction, and slight deficit of working memory. These
behavioral alterations are similar to symptoms of certain
kinds of human psychiatric disorders such as schizophre-
nia and ADHD. These findings indicate that the BRINP1-
KO mouse might serve as a useful animal model in the
discovery of drugs to ameliorate symptoms of relevant hu-
man psychiatric disorders.
Among the three family members, BRINP1 is most
widely expressed in various mouse brain regions includ-
ing hippocampus, and its expression in adult hippocam-
pus is further up-regulated by the increase of neuralactivity [6]. In addition to the promoted neurogenesis
in hippocampus, BRINP1-KO mice showed a set of
abnormal behaviors comparable to the symptoms of human
psychiatric disorders. It has been considered that impair-
ments of certain hippocampal circuitry are associated with
various neurological diseases such as Alzheimer’s disease,
temporal lobe epilepsy, schizophrenia, and mood disor-
ders, even though each disorder displays different re-
gional vulnerability within hippocampal formation [18].
It is highly likely that the abnormal behaviors found in
BRINP1-KO mice were evoked by impairments of hip-
pocampal functions.
The increase of neurogenesis in SGZ of adult BRINP1-
KO mice suggests that BRINP1 negatively regulates pro-
liferation of adult neural stem cells in normal conditions
in accordance with our previous in vitro finding. Thus, we
reported that over-expression of any of the three BRINPs
suppressed the cell-cycle progression at G1/S transition in
both NIH-3T3 cells [4] and ES-derived neural stem cells
(ES-NSCs) [5]. In cultured ES-NSCs, while levels of en-










Figure 8 Neuronal differentiation marker expression in dentate gyrus. (A,B) Doublecortin, (C,D) Calretinin, (E,F) Calbindin expression in
7-week-old mouse dentate gyrus. (A,C,E) Wild-type mice, (B,D,F) BRINP1-KO mice. Scale bar; 50 μm.
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cells, but not upon glial differentiation. These results
suggest that BRINP1 promotes the entry of newborn
cells into quiescent state (G0) to establish terminal dif-
ferentiation during neuronal development and through-
out adulthood.
BRINP1-KO mice showed several abnormal behaviors
comparable to symptoms of human psychiatric disor-
ders. Previously, several studies on various mutant mice
have shown that abnormal behaviors are accompanied
by altered neurogenesis [19]. A decrease in adult neuro-
genesis was reported in mutant mice of schizophrenia-
associated genes such as reeler mice [20,21], NPAS3-KO
mice [22,23] and DISC1 knockdown mice [24]. Consistent
with these findings, a decrease in Ki-67 positive cells was
observed also in SGZ of postmortem brain of schizo-
phrenic patients [25]. It has been suggested that the dimin-
ished adult neurogenesis is involved also in the reduced
cognitive flexibility in major depression, schizophrenia and
dementia [26]. In contrast to these observations, we found
the increase of adult neurogenesis in SGZ of BRINP1-KOmice. A similar increase of adult neurogenesis was also
observed in αCaMKII+/− mice which showed abnormal
behavior such as hyperactivity, decreased anxiety-like
behavior and working memory deficit [27]. It may seem
contradictory that both the increase and decrease in
adult neurogenesis contribute to the expression of similar
abnormal behaviors. However, the products of these mu-
tated genes would possess distinct physiological functions
and influence different aspects of neurogenesis of dentate
granule neurons, such as rate of neurogenesis, course of
differentiation, synapse formation and cell survival. For
example, DISC1 may regulate the rate of development of
newborn neurons [28] and modulate GSK3β/β-catenin
signaling [24], while NPAS3 regulates reelin expression
[29]. It was reported that the neurogenesis in mouse
hippocampus declines with age because of the depletion
of stem cell pool [30]. It is plausible that increased neuro-
genesis in mutant mice accelerates the depletion. It has to
be clarified whether the decreased neurogenesis and cog-
nitive impairment are the consequences of promoted














































Figure 9 Parvalbumin expressing interneurons in BRINP1-KO mice. Representative images of parvalbumin immunoreactivity (green) in hippocampus
of wild-type mice (A-C) and BRINP1-KO mice (D-F). DAPI in blue. (G) The number of parvalbumin expressing cells/section is increased in CA1 subregion of
BRINP1-KO mice in hippocampus. Data are shown as mean ± SEM. (n = 26-28 sections from 3 different mice per genotype; ***: p < 0.001 Wilcoxon
rank-sum test). Scale bar; 100 μm.
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behaviors observed in BRINP1-KO mice are comparable
to the symptoms of schizophrenia and ADHD. Deficient
mice of both calcineurin [31,32] and Schnurri-2 [33,34]
showed increase in locomotor activity, poor social inter-
action and deficit of working memory. Among the sev-
eral potential ADHD model mice, both hyperactivity and
working memory deficit were observed in deficient mice
of dopamine transporter (DAT) [35,36] and gamma amino-
butyric acid transporter (GAT) [37]. Mutant mice overex-
pressing casein kinase 1 (CK1δ) [38] and Grin1 (glutamate
receptor, ionotropic, NMDA1) [39] showed increased loco-
motor activity and abnormal anxiety-like behavior. It has
been shown that dysregulation of the complex interplay
among monoamines (dopamine, norepinephrine and sero-
tonin) is associated with development of ADHD [40]. Con-
sidering the functions of monoamines modulating the
fast neurotransmission of glutamate or GABA, abnor-
mal behaviors observed in BRINP1-KO mice might well
be caused by alteration of the fast neurotransmission inhippocampus or its modulation by the monoamines. To
elucidate the possible link between BRINP1 mutation
and abnormal behaviors, genomic mutation in DBCCR1
locus, a human ortholog of BRINP1, should be analyzed
in patients of psychiatric disorders.
In the present study of BRINP1-KO mice, we found that
excessively generated dentate granule cells can differenti-
ate into DCX-positive immature neurons, but then failed
to continue any further differentiation, maturation or sur-
vival. The excess production of immature neurons and
subsequent elimination may well affect the development
or maintenance of neuronal circuitry in hippocampus and
eventually lead to the development of abnormal behaviors.
It is suggested that BRINP1 is also involved in the particu-
lar processes of differentiation, maturation and survival of
dentate granule neurons.
In addition to the alteration of DCX expression, BRINP1-
KO mice possessed more parvalbumin-expressing interneu-
rons in hippocampal CA1 subregion. It was reported that
the number of parvalbumin-expressing inhibitory neurons
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phrenic brain, this deficit of GABAergic input may cause
impairment of working memory [41]. Several studies on
mutant mice of DISC1, one of the susceptible genes for
schizophrenia, showed the reduction of parvalbumin-
expressing interneurons in prefrontal cortices [42-44] and
CA region of hippocampus [43]. Although the increase of
parvalbumin-expressing interneurons in hippocampal CA1
subregion in BRINP1-KO mice is contrary to these obser-
vations, DISC1 L100P mutant mice also showed the in-
crease of parvalbumin-positive cells in both CA1 and CA2/
3 subregions [45]. The DISC1 L100P mutant mice exhib-
ited schizophrenic-like behaviors including impaired work-
ing memory [46]. Thus, both the impairment of working
memory and the increase of parvalbumin-expressing neu-
rons in hippocampus were observed in this strain, even
though there were controversial results of behavior with
DISC1 L100P mutant mice obtained from different genetic
background [47]. Parvalbumin-expressing GABAergic neu-
rons innervate cell body of CA1 pyramidal neurons and
modulate their glutamatergic output [48]. It was also re-
ported that selective removal of parvalbumin-expressing
neurons in CA1 region leads to impairment of spatial work-
ing memory [49]. Increased inhibitory innervation on CA1
pyramidal neurons in BRINP1-KO mice may also disturb
CA1 output and consequently cause impairment of work-
ing memory.
In the present study it was revealed that the loss of
BRINP1 causes deregulation of neurogenesis and impair-
ments of neuronal differentiation in adult hippocampal
circuitry. In addition, BRINP1-KO mice showed a char-
acteristic set of abnormal behaviors which provides a
useful animal model for a group of human psychiatric
disorders such as schizophrenia and ADHD. Therefore,
confirmation of the causal relationship between alterations
of hippocampal neurogenesis and differentiation and abnor-
mal behaviors of BRINP1-KO mice could provide import-
ant clues for etiological mechanisms of human psychiatric
disorders related to the impairment of hippocampal func-
tions. Future studies focusing on the interactions of BRI
NP1 and its associated molecules should clarify the molecu-
lar mechanisms of the neurogenesis, differentiation and sur-
vival of hippocampal neurons.
Conclusions
In summary, we generated BRINP1-KO mice and analyzed
their behavioral and histochemical alterations. BRINP1-KO
mice showed abnormal behaviors: hyperactivity, decreased
anxiety-like behaviors, poor social interaction, and slight
impairment of working memory, all of which resemble
symptoms of certain human psychiatric disorders. Absence
of BRINP1 causes increase of adult neurogenesis in SGZ
and alteration of neuronal differentiation in hippocampus.
These alterations found in hippocampal neurons might beresponsible for abnormal behaviors in BRINP1-KO mice.
The disturbed hippocampal circuitry formed by BRINP1-
deficiency could serve as an endophenotype for human
psychiatric disorders such as schizophrenia and ADHD.
Materials and methods
Generation of BRINP1-KO mice
A targeting vector for homologous recombination was
designed to replace exon8 (containing 50% of BRINP1
coding sequence) of mouse Brinp1 gene with a PGK-
Neo cassette from pKJ2 [50] (Figure 1A). Approximately
10 kb genomic DNA region which encompass entire tar-
geting vector was obtained by screening of mouse genomic
library and genomic PCR of TT2 mouse embryonic stem
(ES) cell [51] (Gibco-BRL) genomic DNA. Diphtheria toxin
A fragment (DT-A) from pMCDT-A (A +T/pau) [52] was
incorporated in the targeting vector with the purpose of
negative selection. The targeting vector was linearized with
NotI and electroporated into TT2 ES cells. ES cells were
maintained as described previously [53] except that 15%
KnockOut Serum Replacement (Gibco by life technologies)
was used instead of 20% fetal bovine serum. Transfected
cells were selected in the presence of 150 μg/ml Geneticin
(Gibco by life technologies) for 8–10 days. G418 resistant
clones were screened by genomic PCR using forward
primers specific to wild-type allele (BP1 ex8 TV2 D1: 5’-
ATGCTGACCTCCTACGAAGT-3’) or specific to the mu-
tant allele (BP1 ex8 C2 neo: 5’-TCTGGATTCATCGAC
TGTG-3’) in combination with a common reverse primer
(BP1 ex8 TV2 A1: 5’-TGTGAATGGCATATAAGACTGA
TC-3’). The positive ES clones were subjected to Southern
blot analysis to confirm the accomplishment of hom-
ologous recombination. Eight-cell stage embryos were
collected from ICR mice and the zonae pellucidae were
removed, and were then aggregated with ES cells with the
resulting blastocysts transferred to the uterus of pseudo-
pregnant ICR female mice. Male chimeric offspring were
crossed with C57BL/6J female mice to obtain heterozygous
mice. Genotypes were determined by genomic PCR using
forward primers (BP1 ex8 TV2 D1 and BP1 ex8 C2 neo) in
combination with a common reverse primer (BP1 ex8 g34:
5’-CTGAGACCCTTCTTCATGAC-3’). BRINP1 heterozy-
gous mice were backcrossed onto C57BL/6J mice to obtain
a congenic strain. The achievement of backcross breeding
was assessed by PCR-SSLP (simple sequence length poly-
morphism) using 43 different microsatellite markers and
97% of marker’s amplicon sizes were identical to those of
C57BL/6J mice at 6th backcross generation.
Southern blot & Northern blot
Forty μg each of genomic DNA extracted from ES cells
and mouse tail was digested with BamHI. The resultant
fragments were electrophoresed on 0.8% agarose gel and
transferred to nitrocellulose membrane. Then, the blot
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is located at a region adjacent to the long arm of Brinp1
exon8 targeting vector. Radioactive signals were detected
with Image Analyzer FLA-5100 (Fujifilm, Tokyo, Japan).
Northern blot analysis was performed according to the
method described previously [54]. Total RNA extracted
from the adult whole brain was hybridized with 32P-labeled
cRNA probes for Brinp1 (675 nucleotides corresponding to
mouse Brinp1 exon8), Brinp2 (634 nucleotides correspond-
ing to rat Brinp2 exon8, 96% identical to mouse Brinp2)
and Brinp3 (650 nucleotides corresponding to rat Brinp3
exon2-5, 96% identical to mouse Brinp3), respectively. Prior
to hybridization, each membrane was stained with methy-
lene blue to confirm quality and amount of RNA.
Animals
BRINP1-KO mice and wild-type littermates were obtained
by breeding the heterozygote mice which were back-
crossed onto a C57BL/6J line for at least 6 generations.
Mice were maintained under a normal light/dark cycle
(12 h light/12 h dark) with food and water ad libitum. ICR
and C57BL/6J mice were purchased from Japan SLC, Inc.
(Shizuoka, Japan). All animal procedures were performed
in accordance with the Guidelines for Animals Experimen-
tation prepared by the Animal Care and Use Committees




Animals were deeply anesthetized with sodium pento-
barbital, and were exsanguinated by intracardiac perfu-
sion with phosphate buffered saline (PBS) followed by
fixation with perfusion of 4% paraformaldehyde (PFA).
Whole brain was post-fixed in 4% PFA for 1 h at 4°C and
cryoprotected. Each sample embedded in O.C.T. mounting
medium (Sakura Finetek) was cut into 12-μm-thick sec-
tions at around −20°C and stored on slide glasses at −80°C.
Sections were incubated at 4°C over night with primary
antibodies: rabbit anti-Ki-67 (1:500, Abcam), goat anti-
doublecortin (DCX) (1:1,000, Santa Cruz), rabbit anti-
calretinin (1:1,500, SWANT) rabbit anti-calbindin D-28 K
(1:400, SWANT), and mouse anti-Parvalbumin (1:7,500,
SWANT). Then, the sections were incubated at room
temperature for 2 h with fluorescence-conjugated second-
ary antibodies (donkey anti-goat IgG (H + L, 1:1,000, Bio-
tium), goat anti-rabbit IgG (H+ L, 1:1,000, Biotium) or
goat anti-mouse IgG1 (1:2,000, Biotium). Signals were de-
tected with a fluorescence microscope (AxioImager M1,
Zeiss).
BrdU staining
DNA synthesizing cells in the subgranular zone (SGZ)
of the hippocampus were evaluated by incorporation of5-bromo-2’-deoxyuridine (BrdU). BrdU labeling reagent
(mixture of BrdU and 5-fluoro-2’-deoxyuridine, GE Health-
care) was administered intraperitoneally to mice at 10 ml/
kg and the brain was removed 3 h after. Following the post-
fixation with 4% PFA for 15 min, 16-μm-thick cryosections
were rinsed in PBS and were treated with 10 mM citrate
buffer pH6.0 for 10 min in a food steamer [55] for the
purpose of antigen-retrieval. Incubation with antibodies
was performed, as described above, with anti-BrdU anti-
body (1:1,000, Millipore, clone BU-1) and CF488A goat
anti-mouse IgG2a (1:2,000, Biotium) sequentially. In each
mouse, 35 serial sagittal sections beginning 0.48 mm from
midline were used for analysis.Behavior
All behavioral tests were carried out with male mice
that were at least 10 weeks old at the start of testing.
Statistical analysis was conducted using StatView (SAS
Institute, Cary, NC). Data were analyzed by one-way
ANOVA, two-way ANOVA, or two-way repeated-measures
ANOVA, unless noted otherwise. Values in graphs are ex-
pressed as the mean ± SEM. The raw data of behavioral
tests, which are not described in this paper, are disclosed in
the Mouse Phenotype Database (http://www.mouse-pheno-
type.org/).Motor function tests
The neuromuscular strength of the mice was examined by
measurement of grip strength and hanging wire tests. A
grip strength meter (O’Hara & Co., Tokyo, Japan) was used
to assess forelimb grip strength. The mice were lifted and
held by the tail so that their forepaws could grasp a wire
grid. The animals were then gently moved backwards by
pulling the tail with their frontal plane parallel to the sur-
face of the table until they released the grid. The peak force
obtained by the forelimbs of the mouse was recorded in
Newtons (N). Each mouse was tested three times, and the
greatest value was used for statistical analysis. In the wire-
hang test, the mouse was placed on a wire lid and waved
gently until the mouse gripped the wires, then the wire lid
was turned upside down. Latency to fall from the wire lid
was measured.Rotarod test
Motor coordination and balance of the mice were mea-
sured by the performance on the rotarod. Mice were placed
on the rotating drums (3 cm diameter) of an accelerating
rotarod (UGO Basile Accelerating Rotarod, Varese, Italy)
and then mice were forced to walk constantly to avoid fall-
ing from drums. The speed of the rotarod accelerated from
4 to 40 rpm over 5-min period and the latency to fall from
the drum was measured.
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The hot plate test was used to evaluate sensitivity of mice
to a painful stimulus. The mouse was placed on a hot
plate (Columbus Instruments, Columbus, OH) kept at
55.0 ± 0.3°C, and latency to the first hind-paw response,
such as shaking a foot or licking a paw, was recorded.
Open field test
An open field test was used to evaluate the exploratory
activity of mice, and also to assess locomotor activity and
anxiety in a novel environment. Each mouse was placed
in the center of the automated open field apparatus (40 ×
40 × 30 cm; Accuscan Instruments, Columbus, OH). Total
distance traveled (in cm), vertical activity (rearing, measured
by counting the number of photobeam interruptions), time
spent in the center (20 × 20 cm), the beam-break counts for
stereotyped behaviors, and number of fecal boli were all re-
corded. Data were collected for 120 min.
Light/dark transition test
A light/dark transition test was used to evaluate anxiety
of the mice and was performed as described previously
in [56]. The apparatus used for the light/dark transition
test consisted of a cage (21× 42 × 25 cm) divided into
two equal sections by a partition which included a door
(O’Hara & Co., Tokyo, Japan). One chamber was brightly
illuminated (390 lx), while the other was kept dark (2 lx).
Mice were placed into the dark side and allowed to move
freely between the two chambers with the door open for
10 min. The total number of transitions between the
chambers, time spent in the each side, and the first latency
to enter the light side as well as distance traveled (in cm)
were recorded automatically.
Elevated plus maze
The elevated plus maze was used to evaluate anxiety-
related behavior, revealed by conflict in the mouse be-
tween a tendency to explore a novel environment and an
aversion to a bright and open area. The test was per-
formed as previously described in [57]. The elevated plus
maze (O’Hara & Co., Tokyo, Japan) consisted of two open
arms (25 cm × 5 cm) and two closed arms of the same
size. The closed arms were enclosed with 15 cm high
transparent walls. The arms and central square were made
of white plastic plates and were elevated to a height of
55 cm above the floor. To minimize the likelihood of ani-
mals falling from the apparatus, 3 mm high plastic ledges
were provided for the open arms. Arms of the same type
were arranged opposite to each other. Each mouse was
placed in the central square of the maze (5 cm × 5 cm), fa-
cing one of the closed arms. The level of lighting in the
room was adjusted to 100 lx. Mouse behavior was re-
corded during a 10-min test period. The numbers of en-
tries into, and the time spent in the open and enclosedarms, were recorded. For the analysis of data, we used the
following four measures: the percentages of entries into
the open arms, the time spent in the open arm (s), the
number of total entries, and the total distance traveled
(cm). Data acquisition and analysis were performed auto-
matically using Image EP software.
Social interaction (novel environment)
Two mice of identical genotypes previously housed in dif-
ferent cages were placed together into a box (40 × 40 ×
30 cm) and allowed to explore freely for 10 min. Social be-
havior was monitored by a CCD camera, which was con-
nected to PC. Analysis was performed automatically using
Image SI software. Total duration of contact, the number
of contacts, the number of active contacts, mean duration
per contact, and total distance traveled were measured. The
number of active contacts was defined as follows. Images
were captured at 1 frame per second, and distance traveled
between two successive frames was calculated for each
mouse. If the two mice made physical contact with each
other and the distance traveled by either mouse was longer
than 5 cm, the behavior was considered as ‘active contact’.
T-maze alteration test (working memory)
A forced alteration T-maze was used to evaluate working
memory in the mice. Apparatus and experimental proce-
dures of T-maze are described in detail elsewhere [58].
Briefly, a mouse was pre-trained to enter either right or
left compartment at the ends of T-shape alley to get a su-
crose pellet. A single trial of forced alteration task con-
sisted of a forced-choice run and subsequent free-choice
run. In the forced-choice run, the mouse stayed in the
start box until the door was opened. At the same time, the
entrance door for either the right or left compartment was
automatically opened, and mouse entered the opened
compartment to get the pellet. After consuming the pellet,
the exit door leading to the start box was opened and
mouse returned to the start box. In the subsequent free-
choice run, after a 3-s delay, both right and left entrance
doors were opened, and the mouse chose either left or
right compartment. If the mouse entered the compart-
ment opposite to the one which was opened in forced-
choice run, it received a pellet (correct response). If the
mouse entered the same compartment as in the forced-
choice run, it was confined for 10 s with doors closed as a
penalty. One session consisted of 10 consecutive trials
(Figure 6A-C). After 21 sessions, another session was per-
formed with extended delay times (10, 30, 60 s) to increase
the difficulty of the task (Figure 6D).
Social interaction test in home cage
Social interaction monitoring in the home cage was con-
ducted as previously described [32]. The apparatus used
in the home cage was same as that used in locomotor
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housed separately were placed together in a home cage.
Their social behavior was then monitored for 9 days. Im-
ages from each cage were captured at a rate of one
frame per second. Social interaction was measured by
counting the number of particles detected in each frame:
two particles indicated that the mice were not in contact
with each other; and one particle (i.e., the tracking soft-
ware could not distinguish two separate bodies) indi-
cated contact between the two mice. We also measured
locomotor activity during these experiments by quantify-
ing the number of pixels that changed between each pair
of successive frames. Data were averaged over three days
(from 4th day to 6th day, Additional file 1: Figure S1).
Analysis was performed automatically using Image HA
software.Additional file
Additional file 1: Figure S1. Activity level of BRINP1-KO mice in home
cage. (A) Activity levels of mice in home cage. (B) Physical contacts in
home cage. Activity levels were higher during night time in both genotypes.
BRINP1-KO mice were significantly hyperactive during night time compared to
wild-type mice. Data represent averages of one hour activity during 3 days (4th
to 6th day). Figure S2. Neuronal differentiation of BrdU-incorporated cells in
SGZ in BRINP1-KO mice. Representative images of DCX (red) and BrdU (green)
immunostaining (A-B) 2 weeks after BrdU administration. Representative
images of Calbindin (red) and BrdU (green) immunotaining 4 weeks (C-D)
and 5 weeks (E-F) after BrdU administration. Arrows indicate double positive
cells. DAPI in blue. Scale bar; 50 μm. Figure S3. Glial marker expression in
hippocampus of BRINP1-KO mice. Representative images of GFAP (A-F) and
Iba1 (G-L) expressions in 10 weeks wild-type mice and BRINP1-KO mice
hippocampus. No obvious difference was observed between the genotypes in
terms of GFAP and Iba1 expression in hippocampus. DAPI in blue. Scale bar;
50 μm. Figure S4. Oligodendrocyte marker expression in hippocampus of
BRINP1-KO mice. Representative images of MBP expression in wild-type
mice (A-C) and BRINP1-KO mice (D-F). No obvious difference was observed
between the genotypes in terms of MBP expression in hippocampus. Scale
bar; 100 μm. Figure S5. GAD67 expression in hippocampus of BRINP1-KO
mice. Representative images of GAD67 expression in wild-type mice (A) and
BRINP1-KO mice (B). No obvious difference was observed between the
genotypes in terms of GAD67 expression in hippocampus. Scale bar; 200 μm.Abbreviations
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